Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Headings will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
Hodges, Nick, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
Mazurchuk, Richard, Ph.D. richard.mazurchuk@nih.gov 240-276-7126	5E582	Program Officer \| Cancer Biomarkers
Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Program Officer \| Cancer Biomarkers
Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Bresalier, Robert S	University Of Tx Md Anderson Can Ctr United States	Great Lakes New England Clinical Validation Center	5U01CA086400-23	Matthew Young, Ph.D.
Carter, Bob S	Massachusetts General Hospital United States	Standardized Molecular Analyses of Glioma EVs	5R01CA237500-05	Matthew Young, Ph.D.
Castro, Cesar M	Massachusetts General Hospital United States	Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach	5U01CA279858-02	Christos Patriotis, Ph.D., M.Sc.
Chan, Daniel Wanyui	Johns Hopkins University United States	Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions	5U01CA274514-02	Matthew Young, Ph.D.
Cocucci, Emanuele	Ohio State University United States	A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL	5R01CA270251-03	Matthew Young, Ph.D.
Counter, Christopher M	Duke University United States	Adapting K-MDS to detect KRAS-mutant ctDNA	5R21CA257816-03
Deng, Youping	University Of Hawaii At Manoa United States	Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms	5R01CA230514-05	Christos Patriotis, Ph.D., M.Sc.
Deng, Youping	University Of Hawaii At Manoa United States	Profiling genome-wide circulating ncRNAs for the early detection of lung cancer	5R01CA223490-05
Dhakal, Soma	Virginia Commonwealth University United States	Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers	5R61CA278445-03	Christos Patriotis, Ph.D., M.Sc.
Digirolamo, Gregory James	Univ Of Massachusetts Med Sch Worcester United States	Increasing Nodule Detection in Lung Cancer by Non-Conscious Detection of "Missed" Nodules and Machine Learning	5R01CA269903-04	Richard Mazurchuk, Ph.D.
Drake, Richard R.	Medical University Of South Carolina United States	Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids	5R33CA267226-03	Richard Mazurchuk, Ph.D.
Elenitoba-Johnson, Kojo S. J.	Sloan-Kettering Inst Can Research United States	Genomic biomarkers of splenic lymphoma	5R01CA255655-06
Elias, Kevin	Brigham And Women'S Hospital United States	Ovarian cancer risk stratification using circulating miRNAs to assess BRCAness	1R03CA283252-01	Christos Patriotis, Ph.D., M.Sc.
Fan, Rong	Yale University United States	Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies	3U01CA260507-02S3	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Farrar, Christian T	Massachusetts General Hospital United States	Novel metabolomic contrast probes for human lung cancer characterization	5R01CA273010-03	Guillermo Marquez, Ph.D.